PASCAL PUFF 1.23 %
FLUORIDE (HYDROGEN FLUORIDE, SODIUM FLUORIDE) : 1.23 % SODIUM PHOSPHATE MONOBASIC : 0.1 M · DIN 02241675 · PASCAL INTERNATIONAL CORPORATION
Health Canada status: CANCELLED POST MARKET
What is PASCAL PUFF?
PASCAL PUFF 1.23 % contains FLUORIDE (HYDROGEN FLUORIDE, SODIUM FLUORIDE) : 1.23 % SODIUM PHOSPHATE MONOBASIC : 0.1 M. It is listed in the Health Canada Drug Product Database under DIN 02241675, held by PASCAL INTERNATIONAL CORPORATION, supplied as LIQUID for DENTAL administration. Health Canada currently lists it as cancelled post market, status dated 16-Aug-2004. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02241675 |
|---|---|
| Brand name | PASCAL PUFF |
| Generic / active ingredient | FLUORIDE (HYDROGEN FLUORIDE, SODIUM FLUORIDE) : 1.23 % SODIUM PHOSPHATE MONOBASIC : 0.1 M |
| Manufacturer | PASCAL INTERNATIONAL CORPORATION |
| Strength | 1.23 % |
| Dosage form | LIQUID |
| Route of administration | DENTAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A01AA30 COMBINATION (CARIES PROPHYLACTIC AGENTS) |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 16-Aug-2004 |
What can be used instead?
Other Canadian products sharing ATC code A01AA30 COMBINATION (CARIES PROPHYLACTIC AGENTS). 0 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACIDULATED PHOSPHATE FLUORIDE ORAL SOLUTION | .017 % | SOLUTION | PDT IMAGE INC. DBA PRO-DENTEC CANADA | CANCELLED POST MARKET | DIN 02117339 |
| PDF GEL 1.24% | 1.24 % | GEL | LAB BMG INC. | CANCELLED POST MARKET | DIN 00461024 |
| PERFECT CHOICE 0.717% ROOT AND DENTIN DESENS | .14 % | LIQUID | CHALLENGE PRODUCTS INC. | CANCELLED POST MARKET | DIN 02044951 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.